| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |